{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:29:44Z","timestamp":1783348184885,"version":"3.54.6"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.medcli.2020.06.025","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T11:32:56Z","timestamp":1594294376000},"page":"375-381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Agentes terap\u00e9uticos utilizados en 238 pacientes hospitalizados por COVID-19 y su relaci\u00f3n con la mortalidad"],"prefix":"10.1016","volume":"155","author":[{"given":"Mario","family":"Rivera-Izquierdo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Carmen","family":"Valero-Ubierna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Luis","family":"R-delAmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Fern\u00e1ndez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Mart\u00ednez-Diz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezu","family":"Tahery-Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rodr\u00edguez-Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Bel\u00e9n","family":"G\u00e1miz-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s","family":"Barba-Gyengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"G\u00e1mez-Baeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Cabrero-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Antonio","family":"Guirado-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divina Tatiana","family":"Mart\u00edn-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Jes\u00fas","family":"L\u00e1inez-Ramos-Bossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Rosa","family":"S\u00e1nchez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Mancera-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Garc\u00eda-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Miguel","family":"Mart\u00edn-delosReyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Mart\u00ednez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eladio","family":"Jim\u00e9nez-Mej\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2020.06.025_bib0205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5582\/ddt.2020.03008","article-title":"Treatment of SARS-CoV-2: how far have we reached?","volume":"14","author":"Ahsan","year":"2020","journal-title":"Drug Discov Ther."},{"key":"10.1016\/j.medcli.2020.06.025_bib0210","first-page":"170","article-title":"[Potential antiviral therapeutics for 2019 Novel Coronavirus]","volume":"43","author":"Li","year":"2020","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi."},{"key":"10.1016\/j.medcli.2020.06.025_bib0215","doi-asserted-by":"crossref","first-page":"104327","DOI":"10.1016\/j.meegid.2020.104327","article-title":"Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status","volume":"83","author":"Abd El-Aziz","year":"2020","journal-title":"Infect Genet Evol."},{"key":"10.1016\/j.medcli.2020.06.025_bib0220","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijsu.2020.04.001","article-title":"Evidence based management guideline for the COVID-19 pandemic - Review article","volume":"77","author":"Nicola","year":"2020","journal-title":"Int J Surg."},{"key":"10.1016\/j.medcli.2020.06.025_bib0225","doi-asserted-by":"crossref","first-page":"58","DOI":"10.18433\/jpps31002","article-title":"Current drugs with potential for treatment of COVID-19: a literature review","volume":"23","author":"Rabby","year":"2020","journal-title":"J Pharm Pharm Sci."},{"key":"10.1016\/j.medcli.2020.06.025_bib0230","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5582\/ddt.2020.01012","article-title":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)","volume":"14","author":"Dong","year":"2020","journal-title":"Drug Discov Ther."},{"key":"10.1016\/j.medcli.2020.06.025_bib0235","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.6019","article-title":"Pharmacologic treatments for Coronavirus Disease 2019 (COVID-19): a review","author":"Sanders","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.medcli.2020.06.025_bib0240","first-page":"198","article-title":"Update on treatment of COVID-19: ongoing studies between promising and disappointing results","volume":"28","author":"Esposito","year":"2020","journal-title":"Infez Med."},{"key":"10.1016\/j.medcli.2020.06.025_bib0245","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci Trends."},{"key":"10.1016\/j.medcli.2020.06.025_bib0250","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Yao","year":"2020","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.medcli.2020.06.025_bib0255","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2020.06.025_bib0260","doi-asserted-by":"crossref","DOI":"10.1002\/cpt.1844","article-title":"Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection","author":"Du","year":"2020","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.medcli.2020.06.025_bib0265","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.medcli.2020.06.025_bib0270","year":"2020","journal-title":"Efficacy and safety of darunavir and cobicistat for treatment of COVID-19. Identifier NCT04252274"},{"key":"10.1016\/j.medcli.2020.06.025_bib0275","article-title":"National Health Commission and State Administration of Traditional Chinese Medicine","year":"2020","journal-title":"Diagnosis and treatment protocol for novel coronavirus pneumonia"},{"key":"10.1016\/j.medcli.2020.06.025_bib0280","doi-asserted-by":"crossref","first-page":"104786","DOI":"10.1016\/j.antiviral.2020.104786","article-title":"Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro","volume":"178","author":"Choy","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.medcli.2020.06.025_bib0285","doi-asserted-by":"crossref","first-page":"104787","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.medcli.2020.06.025_bib0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents."},{"key":"10.1016\/j.medcli.2020.06.025_bib0295","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3906\/sag-2004-145","article-title":"Antiviral treatment of COVID-19","volume":"50","author":"\u015eim\u015fek Yavuz","year":"2020","journal-title":"Turk J Med Sci."},{"key":"10.1016\/j.medcli.2020.06.025_bib0300","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jiph.2020.03.019","article-title":"Coronavirus disease 2019 (COVID-19): a literature review","volume":"13","author":"Harapan","year":"2020","journal-title":"J Infect Public Health."},{"key":"10.1016\/j.medcli.2020.06.025_bib0305","first-page":"215","article-title":"[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19]","volume":"49","author":"Chen","year":"2020","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban."},{"key":"10.1016\/j.medcli.2020.06.025_bib0310","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","article-title":"Observational study of hydroxychloroquine in hospitalized patients with Covid-19","volume":"382","author":"Geleris","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2020.06.025_bib0315","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.medmal.2020.03.006","article-title":"No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection","volume":"50","author":"Molina","year":"2020","journal-title":"Med Mal Infect."},{"key":"10.1016\/j.medcli.2020.06.025_bib0320","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1473-3099(20)30132-8","article-title":"COVID-19: combining antiviral and anti-inflammatory treatments","volume":"20","author":"Stebbing","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.medcli.2020.06.025_bib0325","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2020.06.025_bib0330","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: a single center experience","volume":"92","author":"Luo","year":"2020","journal-title":"J Med Virol."},{"key":"10.1016\/j.medcli.2020.06.025_bib0335","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2020.06.025_bib0340","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.medcli.2020.06.025_bib0345","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2020.06.025_bib0350","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3332\/ecancer.2020.1023","article-title":"COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?","volume":"14","author":"Russell","year":"2020","journal-title":"Ecancermedicalscience."},{"key":"10.1016\/j.medcli.2020.06.025_bib0355","first-page":"30283-9","article-title":"Eficacia de los pulsos de corticoides en pacientes con s\u00edndrome de liberaci\u00f3n de citocinas inducido por infecci\u00f3n por SARS-CoV-2","volume":"S0025\u20137753","author":"Callejas Rubio","year":"2020","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.medcli.2020.06.025_bib0360","doi-asserted-by":"crossref","first-page":"105955","DOI":"10.1016\/j.ijantimicag.2020.105955","article-title":"The epidemiology, diagnosis and treatment of COVID-19","volume":"55","author":"Zhai","year":"2020","journal-title":"Int J Antimicrob Agents."},{"key":"10.1016\/j.medcli.2020.06.025_bib0365","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of COVID-19 - Preliminary report","author":"Beigel","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2020.06.025_bib0370","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2020.06.025_bib0375","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jmii.2020.02.012","article-title":"Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths","volume":"53","author":"Lai","year":"2020","journal-title":"J Microbiol Immunol Infect."},{"key":"10.1016\/j.medcli.2020.06.025_bib0380","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2020.06.025_bib0385","article-title":"Red Nacional de Vigilancia Epidemiol\u00f3gica","year":"2020","journal-title":"Informe sobre la situaci\u00f3n de COVID-19 en Espa\u00f1a. Informe de COVID-19 n\u00b0 21, 6 de abril de 2020"},{"key":"10.1016\/j.medcli.2020.06.025_bib0390","doi-asserted-by":"crossref","first-page":"106560","DOI":"10.1016\/j.intimp.2020.106560","article-title":"Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: anti-antibodies, immunoglobulins, and corticosteroids","volume":"84","author":"Saghazadeh","year":"2020","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.medcli.2020.06.025_bib0395","doi-asserted-by":"crossref","first-page":"102568","DOI":"10.1016\/j.autrev.2020.102568","article-title":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy","volume":"19","author":"Toniati","year":"2020","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.medcli.2020.06.025_bib0400","doi-asserted-by":"crossref","first-page":"m1328","DOI":"10.1136\/bmj.m1328","article-title":"Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal","volume":"369","author":"Wynants","year":"2020","journal-title":"BMJ."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775320304486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775320304486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T14:56:23Z","timestamp":1654959383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775320304486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0025775320304486"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2020.06.025","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agentes terap\u00e9uticos utilizados en 238 pacientes hospitalizados por COVID-19 y su relaci\u00f3n con la mortalidad","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2020.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}